Viome Life Sciences introduced it closed a $86.5 million oversubscribed Collection C funding spherical, bringing its complete increase to $175 million.
Daring Capital and Khosla Ventures participated within the spherical alongside present and new traders.
The corporate additionally introduced the launch of its Intestine Intelligence Take a look at in 200 CVS places.
WHAT THEY DO
The corporate provides a complete physique intelligence check for customers to acquire meals suggestions and create custom-formulated dietary supplements and probiotics, which the corporate additionally develops and distributes.
Viome additionally provides an oral well being intelligence check with its VRx My·Biotics Oral Lozenges focused at evaluating and bettering one’s oral micro organism.
The Washington-based firm’s Intestine Intelligence Take a look at, out there by way of CVS on-line and in-store, evaluates one’s digestive effectivity, intestine lining well being, gasoline manufacturing, protein fermentation, inflammatory exercise, metabolic health, intestine energetic microbial range, and microbiome-induced stress. The intention is to assist one perceive their intestine well being and acquire suggestions for probiotic strains and prebiotic fibers.
The corporate will use the funds from the Collection C spherical to additional analysis and develop its suite of well being assessments and proceed its growth into retailers.
“Amidst the surge in continual circumstances and the inflow of conflicting dietary recommendation flooding social media, it turned evident {that a} seismic shift was essential. At Viome, we’re not simply speaking about wellness; we’re creating an entire new understanding of what it means to be wholesome by addressing the basis reason for points and never simply the signs. By combining our deep understanding of particular person uniqueness and the microbiome with cutting-edge RNA sequencing and AI know-how, we’re in a position to translate information into actionable insights that may profoundly impression our healthspan and lifespan. I really feel grateful to have the assist of traders and companions who really perceive and recognize our groundbreaking work. The newest funding and our growth into CVS signify extra than simply enterprise milestones; they are a testomony to our dedication and a chance for us to speed up our studying as we get nearer to reaching our mission of serving to billions of individuals dwell higher lives,” Naveen Jain, founder and CEO of Viome, informed MobiHealthNews in an e mail.
MARKET SNAPSHOT
In 2021, Viome introduced it raised $54 million in a pre-Series C convertible funding round. The corporate scored $56 million in Collection B funding in 2019 and $15 million in August 2017.
Viome obtained FDA breakthrough device designation for its mRNA evaluation know-how and AI platform in 2021 that detects early indicators of oral and throat most cancers by way of consumer saliva samples.
Different corporations providing dwelling testing kits embody Reperio Health, the maker of an app-connected dwelling wellness evaluation package marketed to employers; dwelling diagnostics firm Cue Health; and Everly Health, the guardian firm of at-home diagnostics startup EverlyWell and being pregnant and fertility-focused Natalist.
